Prostate Cancer and screening Flashcards
Leuprolide is used to treat
metastatic prostate cancer (it’s form of androgen deprivation therapy) can used with castrate resistant prostate cancer
What type of chemotherapy is used to treat prostate cancer?
taxanes
Treatment of bone pain and delaying pathological fractures in patients with castrate resistant prostate cancer and bone metastasis
parenteral bisphosphonates (pamidronate)
What to consider before giving pamidronate?
renal function.
most common side effect of radiation treatment for localized prostate cancer
sexual dysfunction - radiation damages the nerve.
up to 45% of men become impotent after therapy and frequency increases with time.
Increased risk with androgen deprivation therapy is added to radiation therapy.
Risk of impotence is reduced if avoiding radiation to penile structures.
what can help with sexual dysfunction related to radiation therapy from prostate cancer?
phosphodiesterase inhibitors (sildenafil) may help
secondary cancers from radiation therapy for prostate cancer?
exact risk is difficult to assess because studies didn’t account for factors like concurrent smoking but see bladder and rectal cancers.
other temporary side effects of radiation therapy related to prostate cancer?
urinary frequency and dysuria in 50% of pts but this occurred during treatment with external beam radiation but symptoms resolved within a few weeks of therapy completion. Rarely is there strictures and bladder contractures or cystitis.
transrectal ultrasound for guided prostate biopsy is recommended in
all men with prostatic nodules regardless if PSA value is low or without symptoms.
how is it transrectal ultrasound prostate biopsy done?
given antibiotics prior to procedure and done at urologists office can assess volume in addition improve bipsy results.
endorectal coil MRI is done
with TRUS (transrectal U/S) to better visual seminal vesicle involvement or extraprostatic extension of localized prostate cancer. Helped to look at staging for KNOWN prostate cancer.
indications for transrectal U/S prostate biopsy
when to get repeat transrectal prostate biopsy?
inadequate sample size on initial biopsy
continued high clinical suspicion based on high PSA serum and symptoms
abnormal histology on initial biopsy - atypical small acinar proliferation
side effect of radical prostectomy?
urinary incontinence and due to urethral sphinter injury
- can see 50% of pts develop stress incontinence within 2 months of surgery and incidence dramatically decreases by 10% by 2 years after surgery
treat with nonsurgical solution and do pelvic floor exercises with biofeedback.
if fail this can get surgery with artificial sphincter placement or sling procedure
treatment of ED after radical prostatectomy?
sildenafil can improve ED.
Treatment of prostate cancer is divided into four categories:
observation, active surveillance, and TREATMENT: radiation or radical prostatectomy
observation = watch meant for men with limited life expectancy and significant medical cormorbidities
active surveillance - deferral of curative intent therapy in lieu of regular monitoring for evidence of dx progression. Option for very low risk or low risk prostate cancer with a life expectancy >10 years
Active treatment is for low risk localized prostate cancer, with radiation or radical prostectomy
radiation - low risk localized prostate cancer = external beam radiation or brachytherapy
radical prostectomy remove the prostate
active surveillance of prostate cancer is:
digital rectal exam q12 months
serial serum PSA - if PSA doubles in 3 years need to treat
repeat biopsy is done at 1 year and if no high grade dx then biopsy can be done less often
15 year survival is 97% in selected pts.
most common side effect of radiation treatment of prostate cancer?
short term risk: enteritis and cystitis
ED increases over time with 60-70% of pts have ED by 2 years.
most common side effects of radical prostectomy
immediately after: urinary incontinence; long term only 5-10%
ED more common and persists for years with 40% of pts at 2 years with ED
pts who have intermediate or high risk localized dx are treated wtih
radiation therapy and GnRH agonist to delay dx progression.
pts who have high risk or very high risk prostate cancer get:
six cycles of docetaxel after radiation in addition to androgen deprivation therapy which improves dx free survival and overall survival.